VIVEVE MEDICAL, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Viveve Medical, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2022.
  • Viveve Medical, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2022 was 10.7M shares, a 0.91% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 10.7M +96.3K +0.91% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 10.7M +73.3K +0.69% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 10.6M +299K +2.89% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 10.6M +8.45M +389% Dec 31, 2021 10-Q 2022-11-10
Q3 2021 10.6M -11.1M -51% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 10.6M -5.14M -32.7% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 10.3M +314K +3.13% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 2.17M +1.46M +207% Dec 31, 2020 10-K 2022-03-17
Q3 2020 21.7M +20.2M +1373% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 15.7M -30.8M -66.2% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 10M -36.4M -78.4% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 708K +244K +52.6% Dec 31, 2019 10-K 2021-03-18
Q3 2019 1.47M -30.1M -95.3% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 46.6M +15.1M +48% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 46.4M +15.2M +48.6% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 464K -19M -97.6% Dec 31, 2018 10-K 2020-03-19
Q3 2018 31.5M +12.1M +62.3% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 31.5M +12.1M +62.2% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 31.3M +11.9M +61.5% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 19.5M +8.84M +82.9% Dec 31, 2017 10-K 2019-03-15
Q3 2017 19.4M +8.77M +82.4% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 19.4M +8.8M +83% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 19.3M +11.8M +158% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 10.7M +3.17M +42.3% Dec 31, 2016 10-K 2018-03-16
Q3 2016 10.6M -40.7M -79.3% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 10.6M -40.7M -79.3% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 7.5M -10.8M -59.1% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 7.49M -10.9M -59.2% Dec 31, 2015 10-Q 2016-11-10
Q3 2015 51.3M +33.3M +185% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 51.3M -125M -70.8% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 18.3M -107M -85.3% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 18.3M +11.8M +180% Dec 31, 2014 10-K 2016-03-24
Q3 2014 18M -107M -85.6% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 176M +110M +165% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 125M +69.2M +124% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 6.56M -25.9M -79.8% Dec 31, 2013 10-K 2015-03-16
Q3 2013 125M +93.2M +293% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 66.5M +35.3M +113% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 55.8M +24.8M +80.1% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 32.4M +2.08M +6.86% Dec 31, 2012 10-K 2014-03-31
Q3 2012 31.8M +1.46M +4.8% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 31.2M +833K +2.75% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 31M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 30.4M 0 0% Dec 31, 2011 10-K 2013-03-29
Q3 2011 30.4M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 30.4M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 30.4M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.